These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2460112)

  • 1. Prostatic secretory products as markers of prostatic neoplasms.
    Purvis K; Mevåg B; Teige B; Torjesen P; Jakobsen H; Rui H; Attramadal A
    APMIS Suppl; 1988; 2():224-37. PubMed ID: 2460112
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostatic intraepithelial neoplasia and prostate-specific antigen.
    Brawer MK
    Urology; 1989 Dec; 34(6 Suppl):62-5. PubMed ID: 2481364
    [No Abstract]   [Full Text] [Related]  

  • 3. [The value of prostate-specific antigen].
    Wirth M
    Urologe A; 1991 May; 30(3 Suppl):6. PubMed ID: 1720907
    [No Abstract]   [Full Text] [Related]  

  • 4. [The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers].
    Yamaguchi K; Tanaka M; Kitagawa N; Kotake T; Yanagi S; Ito H
    Hinyokika Kiyo; 1989 Jun; 35(6):987-91. PubMed ID: 2478006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic intraepithelial neoplasia: significance and correlation with prostate-specific antigen and transrectal ultrasound. Proceedings of a workshop of the National Prostate Cancer Detection Project. March 13, 1989, Bethesda, Maryland.
    Urology; 1989 Dec; 34(6 Suppl):2-69. PubMed ID: 2481359
    [No Abstract]   [Full Text] [Related]  

  • 6. Acid phosphatase, alkaline phosphatase and prostate specific antigen: which markers should we choose?
    Cooper EH; Siddall JK; Newling DW; Robinson MR
    Prog Clin Biol Res; 1988; 269():43-56. PubMed ID: 2455911
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer.
    Cooner WH
    Invest Radiol; 1989 Mar; 24(3):257-9. PubMed ID: 2473962
    [No Abstract]   [Full Text] [Related]  

  • 8. [Misleading figures concerning PSA and health examination].
    Fager PJ
    Lakartidningen; 1991 Sep; 88(38):3065-6. PubMed ID: 1717799
    [No Abstract]   [Full Text] [Related]  

  • 9. [The detection of cancer of the prostate. Challenge for the 1990s?].
    Boccon-Gibod L
    Ann Urol (Paris); 1988; 22(6):385-7. PubMed ID: 2464966
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prostatic-specific antigen].
    Boccon-Gibod L
    Ann Urol (Paris); 1988; 22(3):159-60. PubMed ID: 2456711
    [No Abstract]   [Full Text] [Related]  

  • 11. The "hook effect": high concentrations of prostate-specific antigen giving artifactually low values on one-step immunoassay.
    Wolf BA; Garrett NC; Nahm MH
    N Engl J Med; 1989 Jun; 320(26):1755-6. PubMed ID: 2471931
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of the serum determination of specific prostatic antigen in the prediction of prostatic cancer].
    Morote Robles J; Ruibal Morell A; Pont Salvadó A
    Actas Urol Esp; 1988; 12(1):10-4. PubMed ID: 2455436
    [No Abstract]   [Full Text] [Related]  

  • 13. Proteomics in the analysis of prostate cancer.
    Naaby-Hansen S; Nagano K; Gaffney P; Masters JR; Cramer R
    Methods Mol Med; 2003; 81():277-97. PubMed ID: 12725127
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum prostate-specific antigen: its use in diagnosis and management of prostate cancer.
    Lange PH; Brawer MK
    Urology; 1989 Jun; 33(6 Suppl):13-7. PubMed ID: 2471346
    [No Abstract]   [Full Text] [Related]  

  • 15. Biomolecular and clinical characteristics of PSA and other candidate prostate tumor markers.
    Schellhammer PF; Wright GL
    Urol Clin North Am; 1993 Nov; 20(4):597-606. PubMed ID: 7505967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond PSA: utility of novel tumor markers in the setting of elevated PSA.
    Lin DW
    Urol Oncol; 2009; 27(3):315-21. PubMed ID: 19414121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of transrectal ultrasound and prostate-specific antigen in diagnosis of prostatic intraepithelial neoplasia.
    Lee F; Torp-Pedersen ST; Carroll JT; Siders DB; Christensen-Day C; Mitchell AE
    Urology; 1989 Dec; 34(6 Suppl):4-8. PubMed ID: 2481362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on prostate specific antigen, gamma-seminoprotein (gamma-Sm) as a tumor marker of prostatic cancer].
    Kamachi S; Sakurabayashi I; Kawai T
    Rinsho Byori; 1984 Jul; 32(7):781-5. PubMed ID: 6389940
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
    Akimoto S; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of prostate-specific antigen in the management of localized prostatic cancer.
    Walsh PC; Oesterling JE; Epstein JI; Bruzek DJ; Rock RC; Chan DW
    Prog Clin Biol Res; 1989; 303():27-33. PubMed ID: 2476820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.